baber/WOPTO huggingface dataset:
Patent FI-913498-A0 (FI)
Inventor: FRITCH JOHN R
IPC: B01J31/02
Filed: 1991-07-19
Abstract: N-acetyl-para-aminophenol is prepared by contacting 4-hydroxyacetophenone oxime with a Beckmann rearrangement catalyst in an alkyl alkanoate reaction solvent. An integrated process is disclosed wherein 4-hydroxyacetophenone is reacted with a hydroxylamine salt and a base to obtain 4-hydroxyacetophenone oxime, the oxime product is extracted from the resulting reaction mixture with a substantially water-immiscible solvent, and the mixture of oxime and substantially water-immiscible solvent is contacted with a Beckmann rearrangement catalyst to produce N-acetyl-para-aminophenol. Novel Beckmann rearrangement catalysts are used to limit by-product formation in the ester solvent.
Patent FI-913645-A0 (FI)
Inventor: GUPTE ARUN RAJARAM
IPC: A61L15/44
Filed: 1991-07-31
Abstract: The invention concerns the improved transdermal application of pharmacologically active compounds.
Patent FI-914248-A0 (FI)
Inventor: UTKLEV KJELL
IPC: E04B/
Filed: 1991-09-09
Abstract: PCT No. PCT/NO90/00049 Sec. 371 Date Sep. 26, 1991 Sec. 102(e) Date Sep. 26, 1991 PCT Filed Mar. 12, 1990 PCT Pub. No. WO90/10767 PCT Pub. Date Sep. 20, 1990.In a method for eliminating humidity from concrete and masonry structures by means of electroosmosis, current pulses which are supplied in a determined pattern are used. The pulse voltage is limited to +/-40 V. In order to generate the pulses and feed the electrodes a special electronic control device is used.
Patent FI-923075-A0 (FI)
Inventor: FURUMOTO HERBERT
IPC: F23G7/04
Filed: 1992-07-02
Abstract: The control device (RE) for the drop size (d) of the spent liquor (SLD) sprayed into a spent-liquor combustion vessel (LVK) in a spent-liquor combustion plant (LVA) is provided with an upstream set-value element (SO) for the drop size (d*). This set-value element re-forms the set value (d*) with the aid of measured values of the density (D), the calorific value (HQ) and the mass flow (FF) of the spent liquor. The nitrogen oxide (NOx) content and carbon monoxide content (CO) of the waste gas (AG), the ash quality (Q) and the combustion chamber temperature (TF) can be used as further measured parameters. The control system (RE) preferably includes a spray controller (ZR) which acts on a spraying steam feeder (ZDZ) to a spraying nozzle (ZD). In addition, a viscosity controller (VR) can be present which acts on a heating steam feeder (HD) to a preheater (VW) for the spent liquor (SLD). Finally, an ash analyser (AA) can be present which re-forms the ash quality (P), preferably from the ash whiteness (B) and the content of hydratable starting materials (MgOa). In this case, the density (DA), the atomic mass ratio (u) and the pH value of the ash can also be taken into account. <IMAGE>
Patent FI-933531-A0 (FI)
Inventor: ALKER DAVID
IPC: A61P11/00
Filed: 1993-08-10
Abstract: PCT No. PCT/EP92/00163 Sec. 371 Date Jul. 12, 1993 Sec. 102(e) Date Jul. 12, 1993 PCT Filed Jan. 24, 1992 PCT Pub. No. WO92/14734 PCT Pub. Date Sep. 3, 1992.Compounds of formula (1), wherein X is CH or N; Z is CH=CH or S; A is CH2CH2, CH=CH, CH(OH)CH2, or COCH2; B is a direct link or -CH2-, -CH(CH3)- or -C(CH3)2-; or when Z is CH=CH, B may form a cyclopentane ring fused to the attached benzene ring; Y completes a fused benzo or thienyl ring which is optionally substituted by halo or C1-C4alkyl; n is 0, 1 or 2; and m is 0 or 1; are antagonists of both PAF and histamine H1 having utility in the treatment of allergic inflammatory conditions such as allergic rhinitis.
Patent FI-943994-A0 (FI)
Inventor: NAST JEAN-DANIEL
IPC: F16H57/02
Filed: 1994-08-31
Abstract: The present invention relates to a geared-down motor unit comprising:     - a circular motor (1), the drive shaft (2) of which is coupled to a motor pinion (3) for the purpose of transmitting the rotational movement of the drive shaft to an output pinion via an intermediate wheel coupled to the said motor pinion and to the said output pinion,   - a first (6) and a second (7) bearing block arranged on the drive shaft respectively on either side of the circular motor, - a flange of the motor (8), arranged around the said circular motor, holding the said first bearing block, and - a flange of the reducer gear (9) arranged around the said motor and output pinions and the said intermediate wheel, in which:   - the said first and second bearing blocks are mounted, respectively, on either side of the circular motor and of the motor pinion, and - the said second drive block is held by the said flange of the reducing gear.     <IMAGE>
Patent FI-945160-A0 (FI)
Inventor: DAUTH JOCHEN
IPC: C08G77/12
Filed: 1994-11-02
Abstract: In the process, a mixture of the components     A) Organosilicon compounds selected from     A1) organosilanes and   A2) organosiloxanes with the proviso that component A contains at least 0.01-4 mol of alkoxy groups per mol of silicon atoms and that at least some of the organosilicon compounds of component A contain Si-bonded hydrogen B) at least 0.5 mol of water per mol of alkoxy groups in component A, optionally   C) a water-miscible solvent, in the presence of D) ammonia or primary or secondary C1-C4-alkylamine or a compound which liberates ammonia or primary C1-C4-alkylamine with water.
Patent FI-951553-A0 (FI)
Inventor: BACH NICHOLAS JAMES
IPC: A61P37/08
Filed: 1995-03-31
Abstract: A class of novel 1H-indole-3-glyoxylamides is disclosed together with the use of such indole compounds for inhibiting sPLA<sub>2</sub> mediated release of fatty acids for treatment of conditions such as septic shock.
Patent FI-962876-A0 (FI)
Inventor: FROEHLICH KLAUS
IPC: B21K25/00
Filed: 1996-07-17
Abstract: the ends of (4a,5a) of the arms limit a through longitudinal slot (3) and on the rear (6) of the rail (1) are outwardly directed formations (7), which have an opening (8), the edge of which is outwardly and inwardly widened double-conically. The anchors (2) have a head (9) and a cylindrical shaft with a foot, which is held in the opening of one of the outward formations after plastic material deformation. The anchors before fixture to the profile rail have a smaller cross-section outwards from the head over their complete length than the opening on their upper edge and with the foot after fixture engage around the edge of the opening (8) exclusively by material plastic deformation.
Patent IL-57433-A0 (IL)
Title: Pharmaceutical compositions containing cyclopentyl-aldehyde derivatives
IPC: C07C33/12
Filed: 1979-05-29
Abstract: Cyclopentyl-aldehyde derivatives of the general formula   <IMAGE> wherein X and Y, which can be the same or different represent CHO, CH2OH or COOH; Z represents a C1-C3 alkyl group; A represents -CH2-,   <IMAGE> or   <IMAGE> including their geometrical isomers are of value in therapy and may be formulated as therapeutical compositions.
Patent IL-60956-A0 (IL)
Title: Methanephosphonic acid esters containing propargyl groups,their preparation and their use in synergistic pesticidal compound combinations
IPC: A01P7/04
Filed: 1980-09-03
Abstract: 1. Process for the preparation of propargyl methanephosphonates of the general formula (I)  see diagramm : EP0025179,P5,F2  in which R denotes an alkyl, alkenyl or alkinyl radical having a maximum of 4 carbon atoms or an aryl radical, and X and Y denote oxygen or sulphur, characterized in that the relevant ester of methanephosphonyl monochloride or methanephosphonyl dichloride is reacted with at least the equivalent amount of propargyl alcohol in an aqueous two-phase system in the presence of an inorganic base, preferably with sodium hydroxide solution, as the acid-binding agent, in at least the equivalent amount.
Patent IL-73803-A0 (IL)
Title: Recombinant gamma interferons having enhanced stability and methods thereof
IPC: C07K14/52
Filed: 1984-12-11
Abstract: The present invention relates to novel, stable recombinant gamma interferons exhibiting in greater or less degree the antiviral and antiproliferative activity in humans and pH 2 labile properties characteristic of native human gamma interferon. The amino acid sequence of such an interferon comprises, from the N terminus, at leastwherein X is a methionine residue or hydrogen and Y is a glutamine residue or, where X is is hydrogen, Y is either a glutamine or a pyroglutamate residue.
Patent IL-75773-A0 (IL)
Title: Polycyclic ether antibiotics,their production,composition containing them and their use
IPC: C12P17/18
Filed: 1985-07-11
Abstract: A new acidic polycyclic ether antibiotic UK-58,852 has the formula:wherein R and R<sup>1</sup> are both hydrogen, and can be prepared by the submerged aerobic propagation in aqueous nutrient media of Actinomadura sp. ATCC 39697. The antibiotic and its cationic salts are active against a variety of microorganisms and are effective in controlling coccidiosis, enteritis, swine dysentery and theileriosis as well as being effective in promotion of growth and/or improving efficiency of feed utilisation in swine and ruminants. Two minor components, wherein R is H and R<sup>1</sup> is CH<sub>3</sub> and wherein R and R are both CH<sub>3</sub>, have also been isolated from the fermentation.
Patent IL-96262-A0 (IL)
Title: Vehicle anti-theft system
IPC: B60R25/06
Filed: 1990-11-06
Abstract: A vehicle anti-theft device comprising a gear shift lock (14) and an ancillary vehicle anti-theft device which is operated automatically by operation of the gear shift lock (14). <IMAGE>
Patent FI-20001892-A0 (FI)
Inventor: PIETILAE URHO
IPC: B05D1/26
Filed: 2000-08-28
Abstract: The present invention relates to a method of recording an image of a given object onto a substrate. In the method, the object is first defined as the numerical image values at its coordinate locations and then, using these numerical values for control, the final image is recorded with the help of reactive agents capable of undergoing a change of state. Each one of the state-changingly reactive agents is applied onto each point of said substrate in an amount located and controlled by said numerical value of the respective point in the object image, whereupon each one of said amounts of said applied agents is subjected to a reaction causing a change of state. The invention can be implemented to record photographic images, for instance. Other applications are appreciated in the manufacture of printed-circuit boards, printing plates and the like.
Patent FI-20055171-A0 (FI)
Inventor: TAST NIILA
IPC: C02F1/56
Filed: 2005-04-14
Abstract: The invention relates to a method and arrangement for wastewater purification. The wastewater to be purified is conveyed into a septic tank (3), where solids separate from the wastewater. After the solids are separated the purified wastewater is conveyed to filter purification, i.e. to an absorption field (21) or to a filter field (7), for example. The wastewater is conveyed to the filter purification by pumping a predetermined batch of wastewater forward at a time. Purification chemical is dispensed into the septic tank (3) in proportion to the batch to be pumped.
Patent FI-20085408-A0 (FI)
Inventor: AHMANIEMI SAMPPA
IPC: D21F/
Filed: 2008-05-05
Abstract: The forming section of a paper or board machine comprises a double-wire part, where water is removed from the web between two wires, and after the double- wire part there is at least one high-vacuum suction box (20) before a point where the web is transferred to the press section. The vacuum in the suction box (20) is 20-80 kPa, the cover (21) of the suction box is equipped with holes (22), the centre axis (B) of which holes (22) forms a sharp angle (a) with the direction of travel (A) of the wire (10) running over the cover (21), and the open area of the cover (21) is 40-90%. The suction box (20) is placed at the end of the forming section at a location where the dry solids content of the web (W) is at least 6%, preferably at least 10%.
Patent IL-103560-A0 (IL)
Title: Stabilised antibodies
IPC: A61K38/00
Filed: 1992-10-27
Abstract: PCT No. PCT/GB92/01970 Sec. 371 Date Apr. 28, 1994 Sec. 102(e) Date Apr. 28, 1994 PCT Filed Oct. 27, 1992 PCT Pub. No. WO93/08837 PCT Pub. Date May 13, 1993A stabilized immunoglobulin composition comprises at least one immunoglobulin together with a stabilizing amount of a chelator of copper ions such as EDTA or citrate. Preferably the immunoglobulin is an antibody, for example, a recombinant CDR-grafted antibody. A process for enhancing the stability of an immunoglobulin comprises subjecting the immunoglobulin to a purification procedure capable of removing copper ions therefrom. Preferably, the immunoglobulin is rendered substantially free from detectable copper ions as determined, for example, by atomic absorption spectroscopy.
Patent IL-107741-A0 (IL)
Title: Dry mix formulation for bisphosphonic acids
IPC: A61K31/66
Filed: 1993-11-24
Abstract: Prepn. of a tablet contg. a bisphosphonic acid deriv. (BP), comprises (a) forming a mixt. contg. the BP, anhydrous or fast flow lactose, dry binder and disintegrant; (b) opt. adding compression aids, flavours, flavour enhancers, sweeteners, and preservatives; (c) lubricating with a lubricant; and (d) compressing to the desired tablet form. The (BP) are chosen from 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid; and its N-methyl and N,N-dimethyl analogues, 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid and its N,N-dimethyl and N-methyl-N-pentyl analogues; 1-hydroxy-2-(3-pyridyl)ethylidene-1,1-bisphosphonic acid and 4-hydroxymethylene-1,1-bisphosphonic acid piperidine; or their salts. More pref. is 4-amino-1-hydroxybutylidene -1,1-bisphosphonic acid (BP-1) partic. as monosodium salt trihydrate (BP-2). The dry binder is microcrystalline cellulose (MC). The disintegrant is modified starch or cellulose polymer, croscarmellose sodium (CC-Na) or a mixt. esp. CC. The lubricant is Mg stearate. Compsn. range is basic BP 0.5-25, lactose 30-70, MC 30-50, CC-Na 0.5-5 and mg stearate 0.1-2, all %. Closer limits, for BP-2 are BP-2 1-25, lactose 40-60, MC 35-45, CC-Na 0.5-2, and Mg stearate 0.1-1 all %.
Patent IL-108852-A0 (IL)
Title: Section member assembly particularly designed for making sliding main doors
IPC: E05D15/06
Filed: 1994-03-03
Abstract: The present invention relates to a section member assembly, particularly designed for making book and sliding main doors, which comprises upright section members (1,2) and cross section members (3,4) for making fixed frames and wing frames. The main feature of the invention is that the section member assembly further comprises hinge elements (16), including a block member (10) which can be engaged in a seat of the upright (1,2) and can be locked in its engaged position, by means of a threaded dowel (12) engaging in a threaded hole (11) of the block member (10) and bottoming on the bottom portion of the seat. The block members comprise a pair of threaded seats (20), for engaging therein bolts (18), passing through the legs (15) of the hinge elements (16), extending from the cylindric body (17) housing the pivot pin. <IMAGE>
Patent IL-113712-A0 (IL)
Title: Preparation of 2-amino-4,6-dichloropyrimidine
IPC: C07D239/42
Filed: 1995-05-12
Abstract: Prepn. of 2-amino-4,6-dichloropyrimidine (I) comprises: (a) reaction of 2-amino-4,6-dihydroxypyrimidine (II) with an excess of phosphorus oxychloride at 20-80 degrees C, in the presence of triethylamine as acid trapping agent; and (b) isolating (I).
Patent IL-120050-A0 (IL)
Title: Hydroponic culture procedure and device for implementing same
IPC: A01G31/00
Filed: 1997-01-22
Abstract: A succession of suspended conduits are arranged on filiform and parallel supports (2). The upper sheet (1) has holes (6) for planting the respectives plants, the lower sheet (3) without holes acts as a collector, and the intermediary sheets (4) have the same number of holes which are offset longitudinarily with respect to the upper sheet (1). The conduits are assisted by the tube (8) forthe supply of water and nutrients and temperature control. From said tube a microtube or similar comes out above the upper sheet, one for each watering unit, for its individual supply. The liquid comes down in cascade through the conduits and through the holes (7, 7') down to the lower conduit (3), and guides the roots of the plants through the same path as the nutrient. <IMAGE>
Patent IL-126176-A0 (IL)
Title: A pharmaceutical agent containing oestrogen and progesterone for sequential hormone therapy and a packaging unit containing the same
IPC: A61K31/565
Filed: 1997-03-11
Abstract: The invention concerns a medicament containing a combination of individual metering units of an oestrogen and individual metering units of a competitive progesterone antagonist for the separate sequential administration thereof, the medicament being used for hormone replacement therapy. The invention further concerns a pack containing these medicaments.
Patent IL-127138-A0 (IL)
Title: Catheter balloon core wire
IPC: A61M29/02
Filed: 1997-05-19
Abstract: Disclosed herein is a tapering core wire incorporated into the distal end of a catheter. The catheter has a tubular body. Both ends of an inflatable balloon are mounted to the tubular body. The core wire extends from the distal end of the tubular body. In one embodiment, substantially all of the taper of the core wire occurs in the extending portion of the core wire over a length of a least 15 mm but more than 60 mm.
Patent IL-136808-A0 (IL)
Title: Concatenated codes for spread spectrum communication
IPC: H04J13/00
Filed: 1998-12-18
Abstract: Spread spectrum communication techniques and applications using signature sequences are described to reduce the effects of certain transmission impairments such as co-channel interference, multiple access interference and intersymbol interference. A communications method for transmission of data in a network using a unipolar-bipolar signaling scheme, the scheme having code division means for separating differential data on a unipolar or bipolar transmission channel to remove sequence dependent offset by generating sequences using a combination of and concatenation of a selected seed set of sequences is provided.
Patent IL-147446-A0 (IL)
Title: Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
IPC: C12N15/09
Filed: 2000-07-06
Abstract: Recombinant parainfluenza virus (PIV) are provided in which expression of the C, D and/or V translational open reading frame(s) (ORFs) is reduced or ablated to yield novel PIV vaccine candidates. Expression of the C, D and/or V ORF(s) is reduced or ablated by modifying a recombinant PIV genome or antigenome, for example by introduction of a stop codon, by a mutation in an RNA editing site, by a mutation that alters the amino acid specified by an initiation codon, or by a frame shift mutation in the targeted ORF(s). Alternatively, the C, D and/or V ORF(s) is deleted in whole or in part to render the protein(s) encoded thereby partially or entirely non-functional or to disrupt protein expression altogether. C, D and/or V ORF(s) deletion and knock out mutants possess highly desirable phenotypic characteristics for vaccine development. These deletion and knock out mutations changes specify one or more desired phenotypic changes in the resulting virus or subviral particle. Vaccine candidates are generated that show a change in viral growth characteristics, attenuation, plaque size, and/or a change in cytopathogenicity, among other novel phenotypes. A variety of additional mutations and nucleotide modifications are provided within the C, D and/or V ORF(s) deletion or ablation mutant PIV of the invention to yield desired phenotypic and structural effects.
Patent IL-150720-A0 (IL)
Title: Method and device for bonding a non-woven fibre produced by the air-lay method
IPC: D04H1/48
Filed: 2001-01-16
Abstract: The conventional method for production of a multiple-layer, non-woven fibre is by means of the air-lay method, with thermal bonding using bonding fibres. The same method can be applied to a composite non-woven fibre with an intermediate pulp layer. This method of bonding does not reduce the later pilling wear and hardly influences the inner composition of the layers of the composite. According to the invention, the outer non-woven fibre is preferably made from a bicomponent fibre and treated by hydrodynamic needling for bonding, such that not just the surface is bonded, but also the layers are bonded to each other.
Patent IL-196798-A0 (IL)
Title: COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
IPC: C12N15/113
Filed: 2009-01-29
Abstract: The present invention relates to RNA interference using small interfering RNAs (siRNAs) which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt1 and Flk-I/KDR and which inhibit expression of these genes. Diseases which involve angiogenesis stimulated by overexpression of VEGF, such as diabetic retinopathy, age related macular degeneration and many types of cancer, can be treated by administering the small interfering RNAs.
Patent IL-197868-A0 (IL)
Title: Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
Filed: 2009-03-26
Abstract: The present invention provides novel human protein antigens and related antibodies that have been identified as being specifically expressed in association to human Pancreatic Ductal Adenocarcinoma (PDA). In particular, novel phosphorylated isoforms of alpha-enolase have been identified in transformed cell lines of pancreatic origin and antibodies binding such isoforms are specifically present in the sera of PDA patients. These proteins and antibodies can be useful for the diagnosis and the treatment of PDA and other cancers having common molecular features.
Patent RO-134878-A0 (RO)
Title: Antirheumatic ointment with shark liver oil, copaiba balm and bee venom
Inventor: MITITELU MAGDALENA
IPC: A61K35/407
Filed: 2020-11-09
Abstract: The invention relates to an antirheumatic ointment with natural extracts with anti-inflammatory, immunomodulatory, antiseptic, calming and revulsive action. According to the invention, the ointment consists of beeswax, lanolin, shea butter, shark liver oil, castor oil, copaiba balm, eucalyptus essential oil, bee venom and usual preservative solution in a ratio of association, as parts by weight, of: 13... 15:12... 14:15: 10:15: 2... 3:2... 3:0.1: 27.9, having a homogeneous appearance, yellowish-white colour, aromatic scent and pH 5.5...6.
Patent LU-85700-A1 (LU)
Title: New alkenyl substd. benzo:norbornene derivs. and keto intermediates - with vitamin=A activity, useful in pharmaceutical and cosmetic formulation e.g. for treating disease of keratinisation (BE 5.3.86)
Inventor: RESTLE SERGE
IPC: C07C49/792
Filed: 1984-12-20
Abstract: Benzonorbornene derivs. of formula (I), their isomers and salts are new: R1, R3 and R4 = H, 1-8C alkyl, alkoxy or acyloxy, halo or OH; R' = H or 1-6C alkyl; R" is (II) or (III); A2 = CH2OR6 or COR7; R6 = H or 1-6C alkyl; R7 = H, 1-6C alkoxy, aryloxy, benzyloxy, sugar residue, opt. substd. amino, 1-6C alkyl or OH, and the corresp. carboxylic acid salts; A3 is as A2 or also H, 1-6C alkyl, SR5, SOR5 or SO2R5; R5 = 1-6C alkyl. Proviso: where R' = H or Me; R1 and R4 = H and R3 = H or Me, then R" cannot be 4-(COR7)-phenyl; R7 = OH, alkoxy, aryloxy or NR10R11; R10 = alkyl, opt. substd. by OH; R11 = H or as R10. Also new are intermediates (VII); (R gps. are as defined for (I) but R' is not H or Me if R1 and R4 = H and R3 = H or Me).
Patent LU-87746-A1 (LU)
Title: A method, bath and cell for the electrodeposition of tin-bismuth alloys
Inventor: WILSON HAROLD P
IPC: C25D3/56
Filed: 1988-10-14
Abstract: Baths are disclosed for electrodepositing bismuth-tin alloys of all ratios as shown by the Figure. The baths are of the acidic alkylsulfonate-type. Soluble bismuth anodes are used to replenish bismuth in the bath solution. The baths find particular use in electrodepositing eutectic compositions such as 58 % Bi-42 % Sn.